Systematic review of antihypertensive therapies: does the evidence assist in choosing a first-line drug? (Q33696196)

28 July 2017

1 reference

title

Systematic review of antihypertensive therapies: does the evidence assist in choosing a first-line drug? (English)

1 reference

28 July 2017

1 reference

Wright JM

1

1 reference

28 July 2017

Lee CH

series ordinal

2

1 reference

28 July 2017

Chambers GK

series ordinal

3

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 July 1999

1 reference

28 July 2017

number of pages

8

1 reference

Canadian Medical Association Journal

inferred from page(s)

published in

1 reference

28 July 2017

volume

161

1 reference

28 July 2017

issue

1

1 reference

28 July 2017

page(s)

25-32

1 reference

Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: results of the HANE study. HANE Trial Research Group

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1232645

Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1232645

Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1232645

New meta-analysis of treatment trials of hypertension: improving the estimate of therapeutic benefit.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1232645

Hypertension in the elderly. Implications and generalizability of randomized trials

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1232645

Blood pressure reduction in elderly: a randomised controlled trial of methyldopa

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1232645

Meta-analysis in clinical trials

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1232645

Low-dose antihypertensive treatment with a thiazide diuretic is not diabetogenic. A 10-year controlled trial with bendroflumethiazide.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1232645

Randomised trial of treatment of hypertension in elderly patients in primary care

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1232645

Morbidity and mortality in the Systolic Hypertension in the Elderly Program (SHEP) pilot study

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1232645

MAPHY and the two arms of HAPPHY.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1232645

Long-term mortality after 5-year multifactorial primary prevention of cardiovascular diseases in middle-aged men.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1232645

The CASTEL project (CArdiovascular STudy in the ELderly): protocol, study design, and preliminary results of the initial survey

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1232645

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1232645

Effect of two different therapeutic approaches on total and cardiovascular mortality in a Cardiovascular Study in the Elderly (CASTEL).

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1232645

A meta-analysis of outcome trials in elderly hypertensives

30 October 2018

1 reference

12 December 2020

Drug treatment of hypertension in the elderly: a meta-analysis

1 reference

12 December 2020

Clinical results of the Verapamil in Hypertension and Atherosclerosis Study

1 reference

12 December 2020

Effect of antihypertensive treatment on stroke recurrence. Hypertension-Stroke Cooperative Study Group

1 reference

12 December 2020

Failure of therapy to improve prognosis in elderly males with hypertension

1 reference

12 December 2020

Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study

1 reference

12 December 2020

Prospective study on the treatment of mild hypertension in the aged

1 reference

12 December 2020

beta-blockers or diuretics in hypertension? A six year follow-up of blood pressure and metabolic side effects

1 reference

12 December 2020

Treatment of mild hypertension: a five year controlled drug trial. The Oslo study

1 reference

12 December 2020

Identifiers

PMC publication ID

1232645

1 reference

28 July 2017

1 reference